K
Kwang Hyub Han
Researcher at Yonsei University
Publications - 694
Citations - 36674
Kwang Hyub Han is an academic researcher from Yonsei University. The author has contributed to research in topics: Hepatocellular carcinoma & Hepatitis B virus. The author has an hindex of 80, co-authored 692 publications receiving 30974 citations. Previous affiliations of Kwang Hyub Han include University Health System.
Papers
More filters
Journal ArticleDOI
Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update
Yun-Fan Liaw,Nancy H. L. Leung,Jia-Horng Kao,Teerha Piratvisuth,Edward Gane,Kwang Hyub Han,Richard Guan,George K. K. Lau,Stephen L. Locarnini +8 more
TL;DR: The new guidelines include general management, special indications for liver biopsy in patients with persistently normal alanine aminotransferase, time to start or stop drug therapy, choice of drug to initiate therapy, when and how to monitor the patients during and after stopping drug therapy.
Journal ArticleDOI
Long‐term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B
Ting-Tsung Chang,Yun Fan Liaw,Shun Sheng Wu,Eugene R. Schiff,Kwang Hyub Han,Ching-Lung Lai,Rifaat Safadi,Samuel S. Lee,Waldemar Halota,Zachary Goodman,Yunchan Chi,Hui Zhang,R. Hindes,Uchenna H. Iloeje,Suzanne Beebe,Bruce Kreter +15 more
TL;DR: The majority of nucleoside‐naive patients with CHB who were treated with entecavir in this long‐term cohort achieved substantial histological improvement and regression of fibrosis or cirrhosis.
Journal ArticleDOI
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
Jordi Bruix,Tadatoshi Takayama,Vincenzo Mazzaferro,Gar Yang Chau,Jiamei Yang,Masatoshi Kudo,Jianqiang Cai,Ronnie Tung-Ping Poon,Kwang Hyub Han,Won Young Tak,Han Chu Lee,Tianqiang Song,Sasan Roayaie,Luigi Bolondi,Kwan Sik Lee,Masatoshi Makuuchi,Fabricio Souza,Marie Aude Le Berre,Gerold Meinhardt,Josep M. Llovet,Josep M. Llovet +20 more
TL;DR: The data indicate that sorafenib is not an effective intervention in the adjuvant setting for hepatocellular carcinoma following resection or ablation.
Journal ArticleDOI
Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis
Thomas Karlas,David Petroff,Magali Sasso,Jian-Gao Fan,Yu Qiang Mi,Victor de Ledinghen,Manoj Kumar,Monica Lupsor-Platon,Kwang Hyub Han,Ana Carolina Cardoso,Giovanna Ferraioli,Wah-Kheong Chan,Vincent Wai-Sun Wong,Robert P. Myers,Kazuaki Chayama,Mireen Friedrich-Rust,Michel Beaugrand,Feng Shen,Jean Baptiste Hiriart,Shiv Kumar Sarin,Radu Badea,Kyu Sik Jung,Patrick Marcellin,Carlo Filice,Sanjiv Mahadeva,Grace Lai-Hung Wong,Pam Crotty,Keiichi Masaki,Joerg Bojunga,Pierre Bedossa,Volker Keim,Johannes Wiegand +31 more
TL;DR: CAP provides a standardized non-invasive measure of hepatic steatosis and factors such as the underlying disease, BMI and diabetes must be taken into account when interpreting CAP.
Journal ArticleDOI
Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score
Hwai I. Yang,Hwai I. Yang,Man-Fung Yuen,Henry Lik-Yuen Chan,Kwang Hyub Han,Pei-Jer Chen,Do Young Kim,Sang Hoon Ahn,Chien-Jen Chen,Chien-Jen Chen,Vincent Wai-Sun Wong,Wai-Kay Seto +11 more
TL;DR: A simple-to-use risk score that uses baseline clinical variables was developed and validated and accurately estimates the risk of developing HCC at 3, 5, and 10 years in patients with chronic hepatitis B.